Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Normal coronary angiogram~* Left ventricular ejection fraction \< 40%~* NYHA III or IV heart failure symptoms~* Bone marrow reactivity (G-CSF test)~* Presence of viable myocardium~Exclusion Criteria:~* Hematologic malignancy~* Multiorgan failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- SC Group (Type: EXPERIMENTAL): SC therapy,'Bone Marrow Stimulation','CD34+ autologous stem cell transplantation':~In the SC group, CD34+ cells were mobilized by granulocyte colony-stimulating factor and collected via apheresis. Patients underwent myocardial scintigraphy and cells were injected in the artery supplying segments with the greatest perfusion defect
- Controls (Type: NO_INTERVENTION): Patients receiving no cell therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).